44 081 R.P., or 2- [(1,5,10,10a-tetrahydro-3H-thiazolo[3,4-b]isoquinolin-3-ylidine)amino]-4-thiazole acetic acid, is a compound which selectively inhibits rhinovirus in cell cultures. The compound, which was unable to inactivate infectivity of virions, appeared to act prior to RNA and protein synthesis without affecting adsorption or penetration of virus in MRC5 cells. In contrast, it protected intracellular [5-3H]uridine-labeled virions against the effects of RNase treatment, indicating that inhibition of virus uncoating is the mode of action of 44 081 R.P.
As reported previously (13) , 44 081 R.P., or 2-[(1,5,10,lOatetrahydro-3H-thiazolo[3 ,4-b]isoquinolin-3-ylidene)amino]-4-thiazole acetic acid (molecular weight, 345), is a compound which displays selective antirhinovirus properties in cell cultures. Of the 69 rhinovirus samples (12 known serotypes and 57 clinical isolates) that were studied, 48 (70%) were inhibited at nontoxic concentrations (-125 ,ug/ml). 44 081 R.P. appeared to inhibit some early process of rhinovirus replication because under conditions of a single cell growth cycle, the greatest inhibitory effect was noted when the compound was added to cells simultaneously with the infecting virus. No direct virucidal activity was observed. The mechanism of action appeared also to involve some cellular functions because, contrary to that which occurred in MRC5 cells, primary monkey kidney cells, and fetal tonsil fibroblasts, rhinovirus growth in the Ohio line of HeLa cells was not inhibited. In this report we present additional observations on the mode of action of 44 081 R.P., which indicate that the compound inhibits virus uncoating.
MATERIALS AND METHODS
Compound. Compound 44 081 R.P. was synthesized as described previously (European Patent Application 30,198, filed by Rhone-Poulenc Ind. [Chem. Abstr. 96:6715r, January 1982]). Stock solutions of the compound, as sodium salt, were first diluted in phosphate-buffered saline (PBS) and subsequently in tissue culture medium.
Cell cultures. Human embryonic fibroblasts (MRC5, supplied by Bio-Merieux) were grown in basal Eagle medium (with Earle salts) supplemented with 5% newborn calf serum-benzylpenicillin (40 IU/ml)-streptomycin sulfate (40 ,Lg/ml).
Protein synthesis in RV-B-infected cells. Cell monolayers in Falcon multiwell plates were infected for 1 h at 37°C with rhinovirus type 1B (RV-1B) at 20 PFU per cell in the presence or absence of 44 081 R.P. (30 ,ug/ml). Cells were labeled at different times postinfection with 50 ,uCi of
[35S]methionine (800 Ci/mmol) per ml for 1 h. They were then lysed in 0.1 N NaOH-1% sodium dodecyl sulfate (SDS), and macromolecules were precipitated in trichloroacetic acid (TCA) at 10%. Radioactivity was collected on glass fiber filters as described previously (1, 2). For gel electrophoresis experiments, labeled cells (1-h pulse at 5 h postinfection) were washed with PBS and lysed in sample buffer (1). SDS-polyacrylamide gel electrophoresis, fluorography, and autoradiography were performed as described previously (1).
Virus adsorption. Virus adsorption was measured with both rhinovirus type 3 (RV-3) (unlabeled) and RV-1B ([5-3H]uridine labeled); the two serotypes were sensitive to 44 081 R.P. (13) .
RV-3. Confluent MRC5 cells in petri dishes (3.5-cm diameter; Becton Dickinson Labware, Oxnard, Calif.) were incubated with 1.6 x 106 PFU of RV-3 at 4°C in the absence or presence of 44 081 R.P. (30 ,g/ml). At different times cells were washed twice with PBS and lysed by two cycles of freezing and thawing. The number of infectious particles associated with the monolayers was determined by titration in HeLa Ohio cells (13) .
RV-1B. For the preparation of [3H]uridine-labeled virus, the following procedure was used. Confluent MRC5 cell monolayers (in 250-ml bottles; Becton Dickinson Labware) were infected with RV-1B at 0.5 PFU per cell in the presence of 0.4 ,ug of actinomycin D per ml. Later (4 h) the viral inoculum was removed, and fresh medium containing actinomycin D and 100 ,Ci of [5-3H]uridine (60 Ci/mmol) per ml was added. At 20 h postinfection, when a cytopathic effect was observed, cells were disrupted by two cycles of freezing and thawing. The extract was centrifuged at 4°C at 10,000 x g for 10 min in an IEC centrifuge (International Equipment Co., Needham Heights, Mass.). The pellet was discarded, and the supernatant was further centrifuged at 100,000 x g for 2 h in a SW41 rotor (Beckman Instruments, Inc., Fullerton, Calif.). The virus (approximately 60,000 to 90,000 TCA-precipitable cpm per bottle) was recovered from the pellet by mild sonication.
To carry out adsorption experiments, confluent MRC5 cells in Falcon petri dishes were incubated at 4°C with 0.2 ml of [5-3H]uridine-labeled RV-1B (6,000 cpm per dish)-0.4 ,g of actinomycin D per ml to avoid RNA synthesis in the presence of free tritiated uridine that was eventually present in the virus inoculum. At different times postinfection cells were washed three times with ice-cold PBS and lysed in 0.1 N NaOH-1% SDS. Radioactive viral RNA was precipitated with 10% TCA and collected on filters. min at 37°C and then precipitated in TCA to assess the radioactivity that was RNase resistant. Virus penetration and uncoating. [5-3H]uridine-labeled virus was added to confluent MRC5 cultures (in 3.5-cmdiameter petri dishes) and incubated for 1 h at 37°C (unless otherwise specified). Cells were then washed twice in PBS and treated with 0.4 ml of proteinase K (250 p,g/ml) for 10 min at 4°C, to remove nonintemalized virions.
Cells were then collected by scraping and washed three times by low-speed centrifugation. The pellet was sonicated and either immediately precipitated in TCA (as described in the legend to Fig. 1 (Fig. 1A and B) in which protein synthesis was examined.
[35S]methionine incorporation into proteins decreased significantly in MRC5 cells 5 to 6 h postinfection with RV-1B (Fig. 1A) . However, by adding 44 081 R.P. (30 ,ug/ml) at the beginning of infection, the shutdown of protein synthesis was fully prevented. It should be noted that, as indicated in our previous report (13) , the compound was devoid of cytotoxicity at this concentration. In fact, for the first 4 h postinfection, protein synthesis in cells treated with 44 081 R.P. was virtually the same as that in uninfected and untreated cells. It was sufficient for 44 081 R.P. to be present only during the adsorption period to prevent inhibition of protein synthesis (Fig. 1A) . Even though the compound was removed by washing after viral adsorption, its antiviral effect persisted for at least 8 h. This finding strongly supports our previous hypothesis about the mechanism of action of 44 081 R.P., namely, that the compound acts early during the rhinovirus replication cycle.
Similar results were obtained by analysis by polyacrylamide gel electrophoresis of lysates of cells which were pulse-labeled with [35S]methionine between 5 and 6 h postinfection (Fig. 1B) . The electrophoretic profiles of mockinfected cells and of infected cells are shown in lanes 1 and 2, respectively, of Fig. 1B . In the presence of the compound, the switch-off of cellular protein synthesis and the appearance of viral proteins (e.g., 36 and 26 kilodaltons, as shown in lane 2 [ Fig. 1B]) were completely prevented. This effect was obtained in cultures treated with 44 081 R.P., either throughout the incubation period (Fig. 1B, lane 3) or during viral adsorption only (Fig. 1B, lane 4) .
Such observations prompted us to examine in more detail the early events of virus replication, namely, adsorption, penetration, and uncoating. In Fig. 2 is shown the adsorption of two 44 081 R.P.-sensitive rhinovirus serotypes, RV-3 and RV-1B, toward which the compound displays MICs (13) of 3 and 0.15 jxg/ml, respectively. Neither the number of infectious RV-3 particles ( Fig. 2A) R.P.-treated cultures than in the untreated ones (Table 1 , experiments 2 and 3). In other words, 44 081 R.P. appears to inhibit virus decapsidation. It should be noted that because of the lack of activity of the compound in HeLa cells, we found no evidence of an inhibitory effect on RV-1B decapsidation in this cell line (data not shown). DISCUSSION 44 081 R.P. is a synthetic compound which selectively inhibits rhinovirus multiplication in cell cultures at concentrations far below the cytotoxic concentratiQn (250 ,ug/ml). As indicated previously (13), the compound acts on early events of the virus cycle. In this report we further analyzed its mode of action, namely, its effect on adsorption, penetration, and uncoating. Adsorption of two sensitive rhinovirus serotypes (RV-1B and RV-3) was not affected by the compound. Furthermore, the amount of internalized [5-3H]uridine-labeled virions was virtually the same in untreated and drug-treated cultures, indicating that virus penetration is not affected by 44 081 R.P. In contrast, the uncoating step, as determined by the amount of cellpenetrated viral RNA which became RNase sensitive, was remarkably inhibited.
The mechanism of action of several antipicornavirus compounds appears to involve binding to viral particles and their subsequent stabilization. These include compounds such as arildone, rhodanine, chloroquine, 2-thiouracil, and Ro 
